We are live on ! Find out more
BMY icon

Bristol-Myers Squibb

2,367 hedge funds and large institutions have $103B invested in Bristol-Myers Squibb in 2021 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 993 increasing their positions, 944 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 151 | Existing positions closed: 117

13% more call options, than puts

Call options by funds: $1.21B | Put options by funds: $1.07B

5% more repeat investments, than reductions

Existing positions increased: 993 | Existing positions reduced: 944

0% more funds holding

Funds holding: 2,361 → 2,367 (+6)

0.69% less ownership

Funds ownership: 73.56% → 72.87% (-0.69%)

10% less funds holding in top 10

Funds holding in top 10: 78 → 70 (-8)

29% less capital inflows, than outflows

Capital inflows: $4.52B | Capital outflows: $6.39B

Holders
2,367
Holders Change
+6
Holders Change %
+0.25%
% of All Funds
41.46%
Holding in Top 10
70
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-10.26%
% of All Funds
1.23%
New
151
Increased
993
Reduced
944
Closed
117
Calls
$1.21​B
Puts
$1.07​B
Net Calls
+$141​M
Net Calls Change
-⁠$19.6​M

BMY Hedge Fund Activity: Q1 2021 in Review

2,367 of the 5,709 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q1 2021, worth a combined $103B — down 0.33% from $103B a quarter earlier.

Buyers outnumbered sellers: 151 funds opened new BMY positions and 117 closed out — a net gain of 34 holders — while 993 added to existing stakes and 944 trimmed.

The largest buyer was Franklin Resources, adding an estimated $322M. The largest seller was Renaissance Technologies, cutting an estimated $716M.

  • 2,367 institutional investors held Bristol-Myers Squibb (BMY) as of Q1 2021, up from 2,361 in Q4 2020.
  • Funds reported $103B of Bristol-Myers Squibb stock for Q1 2021, down 0.33% quarter-over-quarter.
  • 151 funds opened new Bristol-Myers Squibb positions in Q1 2021 and 117 closed out, a net change of +34 holders.
  • The largest Bristol-Myers Squibb buyer in Q1 2021 was Franklin Resources, an estimated $322M added.
  • The largest Bristol-Myers Squibb seller in Q1 2021 was Renaissance Technologies, an estimated $716M sold.

Based on aggregated 13F filings for Q1 2021.